Successful management of presumed Candida endogenous endophthalmitis with oral voriconazole

Indian Journal of Ophthalmology

Volumn 57, Issue 4, 2009, Pages 306-308

  Biju, Raju ^a   Sushil, Daniel ^b   Georgy, Nainan ^c  

^a Ranjini Eye Care   (India)

^b Grace Eye Hospital   (India)

^c Lakeshore Hospital and Research Center   (India)

Author keywords

Candida endophthalmitis; Endogenous endophthalmitis; Endophthalmitis; Fungal endophthalmitis; Voriconazole

Indexed keywords

ANTIFUNGAL AGENT; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

AGED; ARTICLE; CANDIDIASIS; CASE REPORT; DRUG EFFECT; ENDOPHTHALMITIS; EXUDATE; HUMAN; MALE; METABOLISM; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PATHOLOGY; TREATMENT OUTCOME; VITREOUS BODY;

ADMINISTRATION, ORAL; AGED; ANTIFUNGAL AGENTS; CANDIDIASIS; ENDOPHTHALMITIS; EXUDATES AND TRANSUDATES; HUMANS; MALE; PYRIMIDINES; TREATMENT OUTCOME; TRIAZOLES; VITREOUS BODY;

EID: 68249133643     PISSN: 03014738     EISSN: 19983689     Source Type: Journal    
DOI: 10.4103/0301-4738.53058     Document Type: Article

References (5)

1. Vose M, Beatty S, Charles SJ. Candida endophthalmitis: An unusual complication of prolonged intravenous access. Postgrad Med J 2001;77:119-20.
2. Hariprasad SM, Mieler WF, Holz ER, Gao H, Kim JE, Chi J et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol 2004;122:42-7.
3. Alexandridou A, Reginald AY, Stavrou P, Kirkby GR. Candida Endophthalmitis After Tattooing in an Asplenic Patient. Arch Ophthalmol 2002;120:518-9.
4. Sen P, Gopal L, Sen PR. Intravitreal voriconazole for drug-resistant fungal endophthalmitis: Case series. Retina 2006;26:935-9.
5. Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol 2005; 139:135-40.